Renaissance Capital logo

Commentary & News

US IPO Week Ahead: December IPO market off to slow start


One deal is expected to price in the week ahead. Although, it is not large enough to be included in our IPO stats. After delaying its public debut, BullFrog AI Holdings (BFAI), is scheduled to price in the coming week. It plans to raise $8 million at a $34 million market cap. The pre-revenue company is developing an analytical AI/ML platform for more

US IPO Weekly Recap: November IPO market ends with a quiet week


The November IPO market ended with a quiet week, as the small deals on the calendar pushed back their offering plans. While there was no wave of post-Thanksgiving launches, we could still see some companies join the calendar in the week ahead, though time is more

Deep tech-focused SPAC Alchemy Investments Acquisition 1 files for a $100 million IPO

Alchemy Investments Acquisition 1, a blank check company targeting deep technology with a focus on data analytics, filed on Friday with the SEC to raise up to $100 million in an initial public offering. The company plans to raise $100 million by offering 10 million units at $10. Each unit consists of one share of common stock and one-half of a warrant, exercisable at $11.50. At more

Gene therapy biotech Affinia Therapeutics withdraws $100 million IPO


Affinia Therapeutics, a preclinical biotech developing novel gene therapies for rare diseases and cancer, withdrew its plans for an initial public offering on Friday. It originally filed in January 2022 with a proposed deal size of $100 million. The company had not updated its prospectus since then. The Waltham, MA-based company was founded in 2019 and booked $8 million more